Pierre-Alain Ruffieux, Cytiva’s group executive, bioprocess, discusses completion of the doubling of the company’s liquid ...

Basecamp Research’s antibiotic design and vaccine prediction AI models are now available through Anthropic’s Claude Science.

Officials at Elsevier say the company is expanding LeapSpace, a research-grade AI workspace, with new agentic capabilities.

Shilpa Biologicals says India has the scientific talent and infrastructure to be a trusted partner in ADC drug substance manufacturing.

A new study published in Cell Death Discovery titled, “Sustained dysregulation of iron and glutathione homeostasis induces chronoferroptosis, a persistent ferroptotic adaptation in neuronal ...

The experimental SchistoShield vaccine triggered strong B-cell and T-cell immune memory in early U.S. and African clinical trials.

Insilico Medicine will partner with SK Biopharmaceuticals to discover new artificial intelligence (AI)-based drug candidates for disorders affecting the neuroimmune area of the central nervous system ...

Researchers developed the first human antibody cocktail to completely protect against the lethal Nipah and Hendra virus infection in preclinical models.

The discussion covered plans to increase the agency's headcount and to expedite early through late-stage clinical development in the U.S.

Merck & Co. will partner with Protillion Biosciences to discover multiple new therapy candidates, through a collaboration ...

Researchers say approach could be useful for both initial treatment of bladder cancer as well as treatment refractory subsets of tumors.

Merck KGaA, Darmstadt, Germany, has agreed to acquire Bio-Techne for approximately $11.3 billion, the companies said today, in a deal designed to position the buyer as more of a leader across the life ...